tiprankstipranks
Propanc Biopharma (PPCB)
OTHER OTC:PPCB
US Market
Holding PPCB?
Track your performance easily

Propanc Biopharma (PPCB) Financial Statements

41 Followers

Propanc Biopharma Financial Overview

Propanc Biopharma's market cap is currently ―. The company's EPS TTM is $-0.036; its P/E ratio is ―; Propanc Biopharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -354.31K$ -1.20M$ 447.90K$ -448.54K$ -172.63K
EBITDA$ -291.79K$ -1.41M$ 561.30K$ -442.69K$ -167.37K
Net Income Common Stockholders$ -354.31K$ -358.58K$ -542.50K$ -618.97K$ -493.44K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 9.27K$ 21.09K$ 6.22K$ 71.65K$ 6.63K
Total Assets$ 63.64K$ 72.36K$ 37.34K$ 241.91K$ 180.37K
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 4.17M$ 3.85M$ 3.74M$ 3.81M$ 3.17M
Stockholders Equity$ -4.11M$ -3.78M$ -3.70M$ -3.56M$ -2.99M
Cash Flow-
Free Cash Flow$ -235.51K$ -259.97K$ -102.81K$ -238.88K$ -333.46K
Operating Cash Flow$ -235.51K$ -259.97K$ -102.81K$ -238.88K$ -333.46K
Investing Cash Flow-----
Financing Cash Flow$ 215.70K$ 250.97K$ 66.64K$ 273.93K$ 350.35K
Currency in USD

Propanc Biopharma Earnings and Revenue History

Propanc Biopharma Debt to Assets

Propanc Biopharma Cash Flow

Propanc Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis